# Study to Evaluate the Use of Direct Oral Anticoagulants in UK Clinical Practice For Patients With a First Stroke Attributable to Nonvalvular Atrial Fibrillation

> **NCT05262322** · — · COMPLETED · sponsor: **Daiichi Sankyo UK Ltd, a Daiichi Sankyo Company** · enrollment: 234 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DRUG:** Edoxaban
- **DRUG:** Apixaban
- **DRUG:** Rivaroxaban

## Key facts

- **NCT ID:** NCT05262322
- **Lead sponsor:** Daiichi Sankyo UK Ltd, a Daiichi Sankyo Company
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-15
- **Primary completion:** 2021-07-09
- **Final completion:** 2021-07-09
- **Target enrollment:** 234 (ACTUAL)
- **Last updated:** 2022-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05262322

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05262322, "Study to Evaluate the Use of Direct Oral Anticoagulants in UK Clinical Practice For Patients With a First Stroke Attributable to Nonvalvular Atrial Fibrillation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05262322. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*